Could an HIV drug tame brain inflammation in Alzheimer's? new study aims to find out

NCT ID NCT07553338

Recruiting now Disease control Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen May 06, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This study tests whether a drug called leronlimab is safe for people with Alzheimer's disease or mild cognitive impairment due to Alzheimer's. It also looks at whether the drug can reduce inflammation in the brain. Twenty volunteers aged 50 and older will receive weekly injections for 12 weeks and undergo brain scans, lab tests, and thinking assessments. The goal is to gather safety data and early signs of effect on brain inflammation, which could lead to larger studies on slowing cognitive decline.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Weill Cornell Medicine Brain Health Imaging Institute
RECRUITING

New York, New York, 10065, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ALZHEIMER'S DISEASE MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE